Publications
5600 Results
- Journal / Conference
- JAMA Oncology Apr 1;3(4):516-522; 2016 Dec 15 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID27978579
- PMC
- PMC5665683
- Study Number(s)
- S1115
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
- Journal / Conference
- Lancet Feb 4;389(10068):519-527. Epub 2016 Dec 23.
- Year
- 2017
- Research Committee(s)
- Myeloma
- PMID
- PMID28017406
- PMC
- PMC5546834
- Study Number(s)
- S0777
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without Intent for immediate autologous stem-cell transplant (SWOG S0777): a randomized, open label, phase 3 trial
- Journal / Conference
- Clinical Pharmacology and Therapeutics 2017 Mar;101(3):391-395. Epub 2016 Nov 16.
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID27618250
- PMC
- PMC5320866
- Study Number(s)
- C10403
An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia
- Journal / Conference
- JAMA Oncology Nov 9;3(11):e170231; Epub 2017 Nov 9.2017 Mar 30 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Genitourinary
- PMID
- PMID28358937
- PMC
- PMC5824213
- Study Number(s)
- S1014
Abiraterone acetate for metastatic prostate cancer in patients with suboptimal biochemical response to hormone induction
- Journal / Conference
- JAMA Oncology Jul 1;3(7):944-952; 2017 Feb 9 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Sarcoma
- PMID
- PMID28196207; PMC5727908
- Study Number(s)
- S0033
Long-term results of imatinib mesylate in advanced gastrointestinal stromal tumors (GIST) correlated with next generation sequencing results: SWOG phase III intergroup trial S0033
- Journal / Conference
- Journal of Clinical Oncology May 20;35(15):1695-2017; Apr 6 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID28384065
- PMC
- PMC5455764
- Study Number(s)
- S0518
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
- Journal / Conference
- NPJ Breast Cancer May 19;3:20
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28649660
- PMC
- PMC5460136
- Study Number(s)
- S9630
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
- Journal / Conference
- British Journal of Haematology, 2017 Mar;176(5):759-769; 2016 Dec 19. doi: 10.1111/bjh.14480. [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Lymphoma
- PMID
- PMID27992063
- PMC
- PMC5318240
- Study Number(s)
- S1106
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106
- Journal / Conference
- Journal of the National Cancer Institute Dec 1;109(12)
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID29546345
- PMC
- PMC6075365
- Study Number(s)
- S0221
Supplement use and chemotherapy-induced peripheral neuropathy in patients treated in a SWOG cooperate group trial (S0221): the DELCaP Study
- Journal / Conference
- Cancer Prevention Research 2017 Jan;10(1):45-54; 2016 Oct 24 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID27777235
- PMC
- PMC5510661
- Study Number(s)
- S0000D